Taysha Gene Therapies Inc (TSHA) Unusual Options Activity Today

Checking TSHA unusual options activity helps you spot when traders are making outsized bets on Taysha Gene Therapies Inc before the broader market catches on. Taysha Gene Therapies Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor TSHA unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching TSHA unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking TSHA unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and TSHA unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments.

The company was incorporated in 2019 and is based in Dallas, Texas.

Catalysts rarely arrive without a footprint, and TSHA unusual options activity is often where that footprint shows up first. Our scanner tracks Taysha Gene Therapies Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at TSHA unusual options volume on the call side or chasing put sweeps, Taysha Gene Therapies Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.